Modernizing Clinical Trials Leaves FDA ‘a Large Load of Work’

June 27, 2019, 11:01 AM

Running clinical trials takes time, and so does updating the infrastructure for conducting them. The Food and Drug Administration is working to make those efforts more efficient, and its principal deputy commissioner says the wait will be worth it.

‘Cures’ Kicks in: The 21st Century Cures Act, the sweeping biomedical law from 2016, paved the way for modernization of a system that was designed to ensure drug safety and can cost manufacturers millions before they see any profit.

Dipping Into Data: The FDA is developing new regulatory pathways for shortening review times. One method involves harnessing data sources such as ...

To read the full article log in.

Learn more about A Bloomberg Law subscription.